Last reviewed · How we verify
Giomer pit and fissure sealant with etching
Giomer pit and fissure sealant with etching, marketed by Cairo University, holds a niche position in the dental sealant market. The key composition patent, set to expire in 2028, provides a significant barrier to entry for competitors. However, the lack of revenue data and primary trial results poses a risk in assessing the product's commercial viability and clinical efficacy.
At a glance
| Generic name | Giomer pit and fissure sealant with etching |
|---|---|
| Also known as | Beautisealant with etching |
| Sponsor | Cairo University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Wear Resistance Of Bioactive With And Without Etching Vs. Conventional Resin-Based Fissure Sealants (NA)
- Clinical Performance of Giomer Preceded by Etching Versus Resin-Based Sealants Applied on Permanent Molars Affected by Molar-Incisor Hypo-mineralization (NA)
- Retention Rate of Giomer Pit and Fissure Sealant Applied With or Without Etching (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: